Furthermore, KDM3A upregulation promotes hypoxia-induced HCC proliferation and increases the expression of its target gene adrenomedulin by decreasing H3K9me2 levels at the target promoter [51]. This evidence concerns the gene KDM3A and hepatocellular carcinoma.